VITAL - VITamins to Slow ALzheimer's Disease (Homocysteine Study)
High Dose Supplements to Reduce Homocysteine and Slow the Rate of Cognitive Decline in Alzheimer's Disease (Vitamins to Slow Alzheimer's - VITAL)
Sponsor: Alzheimer's Disease Cooperative Study (ADCS)
Listed as NCT00056225, this PHASE3 trial focuses on Alzheimer's Disease and remains completed. Sponsored by Alzheimer's Disease Cooperative Study (ADCS), it has been updated 6 times since 2003, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Jan 2003
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Alzheimer's Disease Cooperative Study (ADCS)
- National Institute on Aging (NIA)
For direct contact, visit the study record on ClinicalTrials.gov .